Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate Dose Comparison for Meningeal Carcinomatosis
NCT02590510Phase 4Unknown
- Start
- Oct 2015
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of methotrexate in meningeal carcinomatosis (MC). Status: unknown.
02
Drugs
methotrexate
03
Conditions
meningeal carcinomatosis (MC)
Beyond the preview
Go deeper on NCT02590510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590510.